Lupron Depot 45mg Inj/6 Mth Kit

Manufacturer ABBVIE Active Ingredient Leuprolide Injection (Prostate)(loo PROE lide) Pronunciation loo PROE lide
It is used to treat prostate cancer. If you have been given this drug for some other reason, talk with your doctor for more information.
đŸˇī¸
Drug Class
Antineoplastic agent; Gonadotropin-releasing hormone (GnRH) analog
đŸ§Ŧ
Pharmacologic Class
Gonadotropin-releasing hormone (GnRH) agonist
🤰
Pregnancy Category
Category X
✅
FDA Approved
Jan 2007
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lupron Depot 45mg is an injection given every six months to treat advanced prostate cancer. It works by lowering the amount of testosterone (a male hormone) in your body, which can slow down the growth of prostate cancer cells. It's a long-acting form of the medication.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection. If you will be self-administering the injection, your doctor or nurse will instruct you on the proper technique.

Administration Techniques

Some products are designed to be injected into the fatty tissue under the skin, while others are intended for intramuscular injection. If you are unsure about the correct administration method, consult with your doctor or pharmacist.

Precautions and Safety Measures

Before and after handling the medication, wash your hands thoroughly. Wear gloves when mixing and administering the medication to prevent skin contact. Rotate the injection site with each dose to minimize the risk of tissue damage.

Inspecting the Medication

Do not use the medication if the solution appears cloudy, is leaking, or contains particles. Additionally, do not use the medication if the solution has changed color. Avoid applying pressure to the injection site, such as wearing a tight waistband or belt.

Disposal of Sharps

Dispose of used needles and syringes in a designated sharps disposal container. Do not reuse needles or other equipment. When the container is full, follow local regulations for proper disposal. If you have any questions or concerns, consult with your doctor or pharmacist.

Continuing Treatment

Continue using this medication as directed by your doctor or healthcare provider, even if you are feeling well.

Storage and Disposal

In most cases, this medication will be administered in a hospital or doctor's office. If you need to store the medication at home, follow the storage instructions provided by your doctor.

Missed Dose

If you miss a dose, contact your doctor to determine the best course of action.
💡

Lifestyle & Tips

  • Maintain a healthy diet and engage in regular weight-bearing exercise to help preserve bone density and muscle mass.
  • Discuss calcium and vitamin D supplementation with your doctor to support bone health.
  • Monitor for and report any new or worsening symptoms, especially bone pain, urinary issues, or signs of heart problems.
  • Manage hot flashes with lifestyle changes (e.g., cool environment, layered clothing) or discuss medical options with your doctor.
  • Regularly monitor blood sugar and cholesterol levels as advised by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 45 mg administered subcutaneously every 6 months
Dose Range: 45 - 45 mg

Condition-Specific Dosing:

prostateCancer: 45 mg administered subcutaneously every 6 months
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this indication/formulation
Adolescent: Not established for this indication/formulated
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed
Dialysis: No specific adjustment recommended; leuprolide is a peptide and not significantly cleared by dialysis.

Hepatic Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed

Pharmacology

đŸ”Ŧ

Mechanism of Action

Leuprolide is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). It acts as a potent inhibitor of gonadotropin secretion when given continuously. Initially, it causes a transient increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, leading to a temporary increase in testosterone (known as a 'flare'). However, chronic administration of leuprolide leads to downregulation of GnRH receptors in the pituitary, resulting in desensitization and a profound decrease in LH and FSH secretion. This, in turn, leads to a significant reduction in testicular testosterone production to castrate levels.
📊

Pharmacokinetics

Absorption:

Bioavailability: Sustained release over 6 months from depot formulation
Tmax: Initial peak within 4 hours, followed by sustained plateau for 6 months
FoodEffect: Not applicable (parenteral administration)

Distribution:

Vd: Approximately 27 L
ProteinBinding: 43% to 49%
CnssPenetration: Limited

Elimination:

HalfLife: Terminal half-life of leuprolide is approximately 3 hours (for immediate release), but the depot formulation provides sustained release over 6 months.
Clearance: Not fully characterized for depot, but primarily via peptidase degradation.
ExcretionRoute: Primarily via peptidase degradation; a small amount of intact drug and metabolites are excreted renally.
Unchanged: <5% (renal excretion)
âąī¸

Pharmacodynamics

OnsetOfAction: Initial testosterone flare within days, followed by suppression to castrate levels within 2-4 weeks.
PeakEffect: Testosterone suppression to castrate levels (typically <50 ng/dL) by 2-4 weeks.
DurationOfAction: 6 months

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
High Blood Sugar: Confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Infection: Fever, chills, severe sore throat, ear or sinus pain, cough, increased sputum production or change in sputum color, painful urination, mouth sores, or a wound that won't heal.
High Blood Pressure: Severe headache or dizziness, fainting, or changes in vision.
Dehydration: Dry skin, mouth, or eyes, thirst, rapid heartbeat, dizziness, rapid breathing, or confusion.
Liver Problems: Dark urine, fatigue, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin and eyes.
Other Severe Side Effects:
+ New or worsening bone pain
+ Difficulty urinating or changes in urine output
+ Severe back pain
+ Seizures
+ Blood in the urine
+ Abnormal sensations (burning, numbness, or tingling)
+ Severe dizziness or fainting
+ Abnormal heartbeat (fast, slow, or irregular)
+ Shortness of breath, significant weight gain, or swelling in the arms or legs
+ Inability to move
Behavior and Mood Changes: Aggression, crying, depression, mood swings, restlessness, and irritability (especially in children). If you or your child experience any new or worsening behavioral or mood changes, contact your doctor immediately.
Pituitary Gland Problem (Pituitary Apoplexy): Sudden headache, vomiting, fainting, mood changes, eye weakness, inability to move the eyes, or changes in vision. This rare condition usually occurs within 2 weeks of the first dose.
Severe Skin Reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions, which can be life-threatening. Seek medical help immediately if you experience:
+ Red, swollen, blistered, or peeling skin
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, eyes, genitals, or skin
+ Fever, chills, body aches, shortness of breath, or swollen glands

Other Side Effects

Most people taking this medication will not experience severe side effects, but some may encounter mild or moderate side effects. If you experience any of the following, contact your doctor if they bother you or persist:

Headache
Dizziness, fatigue, or weakness
Decreased appetite
Constipation
Upset stomach or vomiting
Difficulty sleeping
Irritation at the injection site
Back, muscle, or joint pain
Flu-like symptoms
Common cold symptoms

This is not an exhaustive list of potential side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Sudden severe bone pain (especially in spine or hips)
  • Difficulty urinating or blood in urine (could indicate disease progression)
  • Chest pain, shortness of breath, or swelling in ankles/feet (signs of cardiovascular issues)
  • Numbness, tingling, or weakness in legs (spinal cord compression)
  • Severe headache, vision changes, or dizziness (rare pituitary apoplexy)
  • Signs of allergic reaction (rash, itching, swelling of face/throat, severe dizziness, trouble breathing)
  • New or worsening diabetes symptoms (increased thirst, urination, unexplained weight loss)
  • Mood changes, depression, or suicidal thoughts
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms.
Your gender, as this medication is not approved for use in females. If you are female, discuss the potential risks with your doctor, particularly if you are pregnant, planning to become pregnant, or are breastfeeding, as this medication may harm an unborn baby.
Any other medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins. This is crucial because this medication may interact with other drugs or worsen certain health conditions.
All your health problems, as they may affect the safety and efficacy of this medication.

To ensure your safety, always consult with your doctor before starting, stopping, or changing the dose of any medication. It is vital to verify that it is safe to take this medication with all your other medications and health conditions.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This drug can alter certain hormone levels in your body, which may lead to various effects such as changes in breast size, breast tenderness, testicle changes, erectile dysfunction, decreased libido, hot flashes, or excessive sweating. If you experience any of these symptoms, discuss them with your doctor.

Regular blood tests and bone density checks are crucial, as directed by your doctor. Additionally, this medication may interfere with certain laboratory tests, so it is vital to notify all your healthcare providers and lab personnel that you are taking this drug.

There is a risk of developing high blood sugar, including new-onset or worsening diabetes, associated with this medication. Monitor your blood sugar levels as advised by your doctor. If you smoke, consult with your doctor, as this medication may also increase cholesterol levels.

Long-term use of this drug may lead to weakened bones, increasing the risk of fractures. If you experience bone pain, contact your doctor immediately. Certain products containing this medication are not approved for use in individuals aged 65 or older or in children, so discuss any concerns with your doctor.

People with bladder blockage or spinal cord compression may be at a higher risk of severe and potentially life-threatening complications. Furthermore, lowering male hormone levels in the body may increase the risk of abnormal heart rhythms, known as prolonged QT interval. If you have any questions or concerns, consult with your doctor.

During the initial few weeks of treatment, you may experience a worsening of symptoms, known as a tumor flare reaction. In rare cases, this can lead to paralysis or even death, particularly in individuals with advanced prostate cancer. If you have urinary blockage or cancer in the spine, inform your doctor, and seek immediate medical attention if you experience difficulty urinating or moving your legs. Report any persistent or bothersome side effects, such as bone pain, numbness, tingling, blood in the urine, or urinary difficulties, to your doctor.

Males taking this medication may have a slightly increased risk of heart attack, stroke, or sudden cardiac death. Although this risk is low, seek immediate medical help if you experience chest pain, weakness on one side of the body, speech or cognitive difficulties, balance problems, facial drooping, or vision changes.

This medication may also affect fertility, so discuss any concerns about fathering a child with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Exaggerated pharmacological effects (e.g., severe hot flashes, fatigue)
  • Injection site reactions

What to Do:

There is no specific antidote for leuprolide overdose. Treatment should be symptomatic and supportive. Call 1-800-222-1222 (Poison Control Center) for advice.

Drug Interactions

🟡

Moderate Interactions

  • Drugs that prolong the QT interval (e.g., Class IA antiarrhythmics, Class III antiarrhythmics, some antipsychotics, macrolide antibiotics, quinolone antibiotics): Although leuprolide itself is not a strong QT prolonger, androgen deprivation therapy may prolong the QT interval. Caution is advised.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Testosterone

Rationale: To establish baseline levels and confirm suppression to castrate levels after treatment initiation.

Timing: Prior to first dose

Prostate-Specific Antigen (PSA)

Rationale: To establish baseline levels and monitor response to therapy for prostate cancer.

Timing: Prior to first dose

Bone Mineral Density (BMD)

Rationale: Long-term androgen deprivation therapy can lead to bone loss.

Timing: Prior to first dose (DEXA scan)

Lipid Panel (Total Cholesterol, LDL, HDL, Triglycerides)

Rationale: Androgen deprivation therapy can affect lipid metabolism.

Timing: Prior to first dose

Blood Glucose / HbA1c

Rationale: Androgen deprivation therapy can affect glucose metabolism and increase risk of diabetes.

Timing: Prior to first dose

Electrocardiogram (ECG)

Rationale: To assess baseline cardiac rhythm, especially if patient has pre-existing cardiac conditions or is on QT-prolonging drugs.

Timing: Prior to first dose (consider)

📊

Routine Monitoring

Serum Testosterone

Frequency: Every 3-6 months (or as clinically indicated) to confirm castrate levels

Target: <50 ng/dL (castrate level)

Action Threshold: >50 ng/dL (investigate non-response or non-compliance)

Prostate-Specific Antigen (PSA)

Frequency: Every 3-6 months (or as clinically indicated) to monitor disease response

Target: Declining or stable low levels

Action Threshold: Rising PSA (suggests disease progression)

Lipid Panel

Frequency: Annually or as clinically indicated

Target: Within normal limits or managed according to guidelines

Action Threshold: Significant dyslipidemia (consider intervention)

Blood Glucose / HbA1c

Frequency: Annually or as clinically indicated

Target: Within normal limits or managed according to guidelines

Action Threshold: Elevated glucose/HbA1c (consider intervention for diabetes)

Bone Mineral Density (BMD)

Frequency: Every 1-2 years for long-term therapy

Target: Maintain optimal BMD

Action Threshold: Significant bone loss (consider bone-sparing agents)

đŸ‘ī¸

Symptom Monitoring

  • Hot flashes
  • Fatigue
  • Bone pain (especially new or worsening)
  • Urinary symptoms (for prostate cancer progression)
  • Cardiovascular symptoms (chest pain, shortness of breath, palpitations)
  • Mood changes, depression
  • Muscle weakness or loss
  • Weight gain
  • Injection site reactions (pain, swelling, redness)

Special Patient Groups

🤰

Pregnancy

Contraindicated in pregnant women. Leuprolide can cause fetal harm when administered to a pregnant woman. It is expected to cause abortion based on its pharmacologic action.

Trimester-Specific Risks:

First Trimester: High risk of fetal harm/abortion due to hormonal effects.
Second Trimester: High risk of fetal harm/abortion due to hormonal effects.
Third Trimester: High risk of fetal harm/abortion due to hormonal effects.
🤱

Lactation

Not recommended during breastfeeding. It is not known whether leuprolide is excreted in human milk. Due to the potential for serious adverse reactions in a breastfed infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: High (potential for hormonal disruption in infant)
đŸ‘ļ

Pediatric Use

This specific formulation (45mg/6 months) is not indicated for pediatric use. Leuprolide acetate is used in pediatric patients for central precocious puberty, but at different doses and formulations.

👴

Geriatric Use

No specific dose adjustment is required based on age. However, geriatric patients may have increased risk of comorbidities (e.g., cardiovascular disease, diabetes, osteoporosis) that are also associated with androgen deprivation therapy. Close monitoring for these conditions is warranted.

Clinical Information

💎

Clinical Pearls

  • Patients should be informed about the initial 'flare' phenomenon (transient increase in testosterone and potential worsening of symptoms) during the first few weeks of therapy. Antiandrogens may be co-administered to mitigate this effect.
  • Long-term use of GnRH agonists is associated with increased risk of bone loss, cardiovascular events, and diabetes. Comprehensive monitoring and management of these risks are crucial.
  • Ensure proper subcutaneous injection technique for the 6-month depot formulation to ensure sustained release.
  • Patients should be advised to report any new or worsening neurological symptoms (e.g., weakness, numbness) as spinal cord compression can occur in patients with vertebral metastases.
  • Lupron Depot 45mg/6 month is a long-acting formulation, which can improve patient adherence compared to more frequent injections.
🔄

Alternative Therapies

  • Other GnRH agonists (e.g., goserelin, triptorelin)
  • GnRH antagonists (e.g., degarelix, relugolix)
  • Androgen receptor inhibitors (e.g., enzalutamide, apalutamide, darolutamide)
  • Androgen synthesis inhibitors (e.g., abiraterone)
  • Bilateral orchiectomy (surgical castration)
  • Chemotherapy (e.g., docetaxel, cabazitaxel) for metastatic castration-resistant prostate cancer
💰

Cost & Coverage

Average Cost: Varies widely, typically several thousand USD per 6-month kit
Insurance Coverage: Specialty Tier (requires prior authorization, often covered by Medicare Part D and commercial plans for approved indications)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to consult with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount, and the time it occurred.